Literature DB >> 8542752

Growth of clostridia and preparation of their neurotoxins.

C C Shone1, H S Tranter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8542752     DOI： 10.1007/978-3-642-85173-5_7

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN： 0070-217X            Impact factor:   4.291


× No keyword cloud information.
  13 in total

1.  Characterization of botulinum neurotoxin type A neutralizing monoclonal antibodies and influence of their half-lives on therapeutic activity.

Authors:  Christelle Mazuet; Julie Dano; Michel R Popoff; Christophe Créminon; Hervé Volland
Journal:  PLoS One       Date:  2010-08-26       Impact factor: 3.240

2.  Generation of high-titer neutralizing antibodies against botulinum toxins A, B, and E by DNA electrotransfer.

Authors:  C Trollet; Y Pereira; A Burgain; E Litzler; M Mezrahi; J Seguin; M Manich; M R Popoff; D Scherman; P Bigey
Journal:  Infect Immun       Date:  2009-02-23       Impact factor: 3.441

3.  Bivalent recombinant vaccine for botulinum neurotoxin types A and B based on a polypeptide comprising their effector and translocation domains that is protective against the predominant A and B subtypes.

Authors:  Clifford Shone; Heidi Agostini; Joanna Clancy; Mili Gu; Huei-Hsiung Yang; Yanfang Chu; Virginia Johnson; Makie Taal; Joanna McGlashan; John Brehm; Xiaomi Tong
Journal:  Infect Immun       Date:  2009-04-27       Impact factor: 3.441

4.  Development of novel assays for botulinum type A and B neurotoxins based on their endopeptidase activities.

Authors:  B Hallis; B A James; C C Shone
Journal:  J Clin Microbiol       Date:  1996-08       Impact factor: 5.948

5.  Preparation of Cerebellum Granule Neurons from Mouse or Rat Pups and Evaluation of Clostridial Neurotoxin Activity and Their Inhibitors by Western Blot and Immunohistochemistry.

Authors:  Domenico Azarnia Tehran; Marco Pirazzini
Journal:  Bio Protoc       Date:  2018-07-05

Review 6.  Regulatory Networks Controlling Neurotoxin Synthesis in Clostridium botulinum and Clostridium tetani.

Authors:  Michel R Popoff; Holger Brüggemann
Journal:  Toxins (Basel)       Date:  2022-05-24       Impact factor: 5.075

7.  Detection and quantification of botulinum neurotoxin type a by a novel rapid in vitro fluorimetric assay.

Authors:  Hervé Poras; Tanja Ouimet; Sou-Vinh Orng; Marie-Claude Fournié-Zaluski; Michel R Popoff; Bernard P Roques
Journal:  Appl Environ Microbiol       Date:  2009-05-08       Impact factor: 4.792

8.  Content of botulinum neurotoxin in Botox®/Vistabel®, Dysport®/Azzalure®, and Xeomin®/Bocouture®.

Authors:  Jürgen Frevert
Journal:  Drugs R D       Date:  2010

9.  Brevenal inhibits pacific ciguatoxin-1B-induced neurosecretion from bovine chromaffin cells.

Authors:  César Mattei; Peter J Wen; Truong D Nguyen-Huu; Martha Alvarez; Evelyne Benoit; Andrea J Bourdelais; Richard J Lewis; Daniel G Baden; Jordi Molgó; Frédéric A Meunier
Journal:  PLoS One       Date:  2008-10-20       Impact factor: 3.240

10.  Development of human-like scFv-Fc antibodies neutralizing Botulinum toxin serotype B.

Authors:  Christine Rasetti-Escargueil; Arnaud Avril; Siham Chahboun; Rob Tierney; Nicola Bak; Sebastian Miethe; Christelle Mazuet; Michel R Popoff; Philippe Thullier; Michael Hust; Thibaut Pelat; Dorothea Sesardic
Journal:  MAbs       Date:  2015-09-18       Impact factor: 5.857
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.